Handelsbanken Fonder AB - REVOLUTION MEDICINES INC ownership

REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of REVOLUTION MEDICINES INC
ValueSharesWeighting
Q3 2023$393
+9.8%
14,200
+6.0%
0.00%0.0%
Q2 2023$358
+43.8%
13,400
+16.5%
0.00%
+100.0%
Q1 2023$249
-9.1%
11,5000.0%0.00%
-50.0%
Q4 2022$274
-99.9%
11,5000.0%0.00%0.0%
Q3 2022$227,000
+1.3%
11,5000.0%0.00%
+100.0%
Q2 2022$224,000
-23.5%
11,5000.0%0.00%
-50.0%
Q1 2022$293,000
-30.7%
11,500
-31.5%
0.00%0.0%
Q4 2021$423,000
+27.0%
16,800
+38.8%
0.00%0.0%
Q3 2021$333,000
-13.3%
12,1000.0%0.00%0.0%
Q2 2021$384,000
+4.6%
12,100
+51.2%
0.00%0.0%
Q1 2021$367,000
+15.8%
8,0000.0%0.00%0.0%
Q4 2020$317,0008,0000.00%
Other shareholders
REVOLUTION MEDICINES INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 5,104,130$99,479,00040.69%
Ponoi II Management, LLC 685,011$13,351,00036.28%
Nextech Invest Ltd. 3,939,529$76,781,00025.90%
Ponoi Management, LLC 685,011$13,351,00021.08%
Column Group LLC 4,395,050$85,660,00018.23%
TRV GP IV, LLC 1,419,900$27,674,00018.20%
Boxer Capital, LLC 3,484,264$67,908,0004.30%
Casdin Capital, LLC 2,370,000$46,191,0003.91%
Cormorant Asset Management, LP 1,995,066$38,884,0002.94%
EcoR1 Capital, LLC 4,278,069$83,380,0002.88%
View complete list of REVOLUTION MEDICINES INC shareholders